Welcome Guest | Register / Login

Global Markets Direct Market Research Reports

Sort By
Title Published Price Buy Now
Muscle Invasive Bladder Cancer (MIBC) – Pipeline Review, H2 2012
By Global Markets Direct
Muscle Invasive Bladder Cancer (MIBC) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Muscle Invasive Bladder Cancer (MIBC) - Pipeline Review, H2 2012'', provides an overview of the Muscle Invasive...
Jul 2012 $ 500
Refractory Multiple Myeloma – Pipeline Review, H2 2012
By Global Markets Direct
Refractory Multiple Myeloma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Refractory Multiple Myeloma - Pipeline Review, H2 2012'', provides an overview of the Refractory Multiple Myeloma therape...
Jul 2012 $ 500
Epithelial Ovarian Cancer – Pipeline Review, H2 2012
By Global Markets Direct
Epithelial Ovarian Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Epithelial Ovarian Cancer - Pipeline Review, H2 2012'', provides an overview of the Epithelial Ovarian Cancer therapeutic p...
Jul 2012 $ 500
B-Cell Leukemia – Pipeline Review, H2 2012
By Global Markets Direct
B-Cell Leukemia – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''B-Cell Leukemia - Pipeline Review, H2 2012'', provides an overview of the B-Cell Leukemia therapeutic pipeline. This report provides ...
Jul 2012 $ 500
Neuro Endocrine (Carcinoid) Carcinoma – Pipeline Review, H2 2012
By Global Markets Direct
Neuro Endocrine (Carcinoid) Carcinoma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Neuro Endocrine (Carcinoid) Carcinoma - Pipeline Review, H2 2012'', provides an overview of the Neuro Endocrine...
Jul 2012 $ 500
Malignant Neoplasms – Pipeline Review, H2 2012
By Global Markets Direct
Malignant Neoplasms – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Malignant Neoplasms - Pipeline Review, H2 2012'', provides an overview of the Malignant Neoplasms therapeutic pipeline. This repo...
Jul 2012 $ 500
Recurrent Malignant Glioma – Pipeline Review, H2 2012
By Global Markets Direct
Recurrent Malignant Glioma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Recurrent Malignant Glioma - Pipeline Review, H2 2012'', provides an overview of the Recurrent Malignant Glioma therapeuti...
Jul 2012 $ 500
Endobronchial Cancer – Pipeline Review, H2 2012
By Global Markets Direct
Endobronchial Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Endobronchial Cancer - Pipeline Review, H2 2012'', provides an overview of the Endobronchial Cancer therapeutic pipeline. This r...
Jul 2012 $ 500
Leiomyosarcoma – Pipeline Review, H2 2012
By Global Markets Direct
Leiomyosarcoma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Leiomyosarcoma - Pipeline Review, H2 2012'', provides an overview of the Leiomyosarcoma therapeutic pipeline. This report provides inf...
Jul 2012 $ 500
Transitional Cell Cancer (Urothelial Cell Cancer) – Pipeline Review, H2 2012
By Global Markets Direct
Transitional Cell Cancer (Urothelial Cell Cancer) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2012'', provides an overvie...
Jul 2012 $ 500
Esophageal Tumor – Pipeline Review, H2 2012
By Global Markets Direct
Esophageal Tumor – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Esophageal Tumor - Pipeline Review, H2 2012'', provides an overview of the Esophageal Tumor therapeutic pipeline. This report provid...
Jul 2012 $ 500
Malignant Pleural Mesothelioma – Pipeline Review, H2 2012
By Global Markets Direct
Malignant Pleural Mesothelioma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Malignant Pleural Mesothelioma - Pipeline Review, H2 2012'', provides an overview of the Malignant Pleural Mesotheliom...
Jul 2012 $ 500
Brain Tumor – Pipeline Review, H2 2012
By Global Markets Direct
Brain Tumor – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Brain Tumor - Pipeline Review, H2 2012'', provides an overview of the Brain Tumor therapeutic pipeline. This report provides information ...
Jul 2012 $ 500
Colon Cancer – Pipeline Review, H2 2012
By Global Markets Direct
Colon Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Colon Cancer - Pipeline Review, H2 2012'', provides an overview of the Colon Cancer therapeutic pipeline. This report provides informati...
Jul 2012 $ 500
Hodgkin Lymphoma – Pipeline Review, H2 2012
By Global Markets Direct
Hodgkin Lymphoma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Hodgkin Lymphoma - Pipeline Review, H2 2012'', provides an overview of the Hodgkin Lymphoma therapeutic pipeline. This report provid...
Jul 2012 $ 500
Substance (Drug) Abuse – Pipeline Review, H2 2012
By Global Markets Direct
Substance (Drug) Abuse – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Substance (Drug) Abuse - Pipeline Review, H2 2012'', provides an overview of the Substance (Drug) Abuse therapeutic pipeline. ...
Jul 2012 $ 500
Metastatic Pancreatic Cancer – Pipeline Review, H2 2012
By Global Markets Direct
Metastatic Pancreatic Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Metastatic Pancreatic Cancer - Pipeline Review, H2 2012'', provides an overview of the Metastatic Pancreatic Cancer ther...
Jul 2012 $ 500
Hepatic (Liver) Tumor – Pipeline Review, H2 2012
By Global Markets Direct
Hepatic (Liver) Tumor – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Hepatic (Liver) Tumor - Pipeline Review, H2 2012'', provides an overview of the Hepatic (Liver) Tumor therapeutic pipeline. Thi...
Jul 2012 $ 500
Diffuse Large B-Cell Lymphoma – Pipeline Review, H2 2012
By Global Markets Direct
Diffuse Large B-Cell Lymphoma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2012'', provides an overview of the Diffuse Large B-Cell Lymphoma t...
Jul 2012 $ 500
Ureter Cancer – Pipeline Review, H2 2012
By Global Markets Direct
Ureter Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Ureter Cancer - Pipeline Review, H2 2012'', provides an overview of the Ureter Cancer therapeutic pipeline. This report provides inform...
Jul 2012 $ 500
Acute Lymphoblastic Lymphoma – Pipeline Review, H2 2012
By Global Markets Direct
Acute Lymphoblastic Lymphoma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Acute Lymphoblastic Lymphoma - Pipeline Review, H2 2012'', provides an overview of the Acute Lymphoblastic Lymphoma ther...
Jul 2012 $ 500
Fallopian Tube Cancer – Pipeline Review, H2 2012
By Global Markets Direct
Fallopian Tube Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Fallopian Tube Cancer - Pipeline Review, H2 2012'', provides an overview of the Fallopian Tube Cancer therapeutic pipeline. Thi...
Jul 2012 $ 500
Low-Grade Astrocytoma – Pipeline Review, H2 2012
By Global Markets Direct
Low-Grade Astrocytoma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Low-Grade Astrocytoma - Pipeline Review, H2 2012'', provides an overview of the Low-Grade Astrocytoma therapeutic pipeline. Thi...
Jul 2012 $ 500
Endometrial Cancer – Pipeline Review, H2 2012
By Global Markets Direct
Endometrial Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Endometrial Cancer - Pipeline Review, H2 2012'', provides an overview of the Endometrial Cancer therapeutic pipeline. This report ...
Jul 2012 $ 500
Gastrointestinal Stromal Tumor (GIST) – Pipeline Review, H2 2012
By Global Markets Direct
Gastrointestinal Stromal Tumor (GIST) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H2 2012'', provides an overview of the Gastrointestina...
Jul 2012 $ 500
Live Chat
Live Chat by Comm100